Executive Summary
Nitrosamines, Elemental Impurities, Extractable and Leachable – A New Normal for the Pharma Industry
Summary: Download this article to learn more about the current regulatory expectations for E&L, elemental impurities and nitrosamines testing, as well as the latest advances in analytical methods.
View Now
Webinars
Navigating Policy, Funding, CMC and Regulatory Dynamics for Successful Orphan Drug Development
During this webinar, industry experts will teach valuable insights, strategies, and practical knowledge to overcome the challenges and pave a successful path to orphan drug development and commercialization.
View Now
Executive Summary
Advancing Lipid-Based Formulations and Softgels in Drug Development
Summary: This executive summary highlights lipid-based formulations (LBFs) in pharmaceutical development, emphasizing their complex composition and the critical role of careful formulation selection in the early stages of drug development.
View Now
Video
Trends and Challenges in Pharmaceutical Development
Summary: Watch this video as experts discuss the complexities and opportunities for lipid-based formulations to improve drug delivery.
View Now
Webinars
HME: Debunking the Myths Around Oral Dosage Form Development Limitation
Summary: In this webinar industry experts delve into HME principles, mechanisms, and advantages over traditional methods
View Now
Webinars
Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations
Summary: In this webinar experts share insights into critical considerations & strategies for dosing lipid formulations in preclinical models
View Now
Webinars
Developing and Manufacturing Minitablets to Extend Drug Lifecycle
During this webinar, industry experts will navigate the intricate journey of drug development, exploring how minitablets have redefined formulation strategies, efficacy, and patient-centric solutions as well as options for lifecycle management.
View Now
Case Study
Enhancing Drug Performance Through Lipid-Based Formulations for CNS Indication
Read this case study to learn how a company engaged with Catalent to develop an oral lipid-based formulation that would lead to a more predictable and reliable drug response.
View Now
Offering Fact Sheet
Small Molecule Analytical Equipment List
Summary: Explore Catalent’s extensive standalone analytical services with industry leading equipment and network of over 3,000 scientists. Learn how our deep expertise supporting pharmaceuticals, biologics (protein, cell and therapy, and vaccines), inhalation (nasal and dry powder inhaler), drug product/substance and in-process samples could help accelerate your drug product's journey.
View Now
Webinars
Mitigating the Risk of Pitfalls in Nasal Drug Product Development, Testing and Manufacturing
In this webinar, experts discuss problems common to the development, testing and manufacturing of intranasal drug products, their potential causes, and possible consequences.
View Now
